Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer

Archives of Clinical Nephrology
Case Report
Gemcitabine (2’,2’-difl uorodeoxycytidine) is a potent pyrimidine antimetabolite and was introduced in 1987. It is commonly used for various tumors including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian can cer and renal cell carcinoma at advanced stages.
https://www.peertechz.com/articles/thrombotic-microangiopathy-caused-by-gemcitabine-in-a-patient-with-duodenal-cancer.pdf
  

Comments

Popular posts from this blog

Peertechz is not Predatory Open Access Publisher

The prevention and cure research of emergency intervention therapy of balloon occlusion of LAD occurring reperfusion arrhythmia

Case Report: Reynolds Syndrome